Related Experiment Video
Updated: Jun 20, 2026
06:57
Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
Published on: June 14, 2019
Integrating human papillomavirus vaccination in cervical cancer control programmes
Eduardo L Franco1, François Coutlée, Alex Ferenczy
1Department of Oncology, McGill University, Montréal, Qué., H2W 1S6 Canada. eduardo.franco@mcgill.ca
Public Health Genomics
|August 18, 2009
Summary
Human papillomavirus (HPV) DNA testing offers a more sensitive cervical cancer screening method than Pap cytology, especially in resource-poor settings. Combining HPV testing with prophylactic vaccines presents a powerful strategy to combat cervical cancer globally.
Area of Science:
- Oncology
- Virology
- Public Health
Background:
- Cervical cancer screening with Pap cytology has reduced mortality in high-income nations but remains ineffective in resource-poor countries.
- Infection with oncogenic human papillomavirus (HPV) types is a necessary cause of cervical cancer, driving new preventive strategies.
- Cervical cancer remains a significant public health challenge in many parts of the world due to limitations in current screening programs.
Purpose of the Study:
- To evaluate the utility of HPV DNA testing as a primary screening tool for cervical cancer.
- To assess the potential of HPV testing in improving screening program quality and cost-effectiveness.
- To explore the combined impact of HPV testing and prophylactic vaccination in cervical cancer prevention.
Main Methods:
- Review of current screening practices and emerging molecular diagnostics for cervical cancer.
- Analysis of the sensitivity and specificity of HPV DNA testing compared to Pap cytology.
- Examination of clinical trial data for prophylactic HPV vaccines (types 16 and 18).
Main Results:
- HPV DNA testing demonstrates higher sensitivity and comparable specificity to Pap cytology for detecting cervical pre-cancers.
- HPV testing as a primary screen with Pap triage can enhance screening quality and allow for longer intervals, reducing costs.
- Prophylactic HPV vaccines (16/18) show high efficacy and safety in preventing persistent infections and pre-cancers.
Conclusions:
- HPV DNA testing is a valuable tool for cervical cancer screening, particularly in resource-limited settings and the post-vaccine era.
- Integrating HPV testing with Pap triage offers a more effective and potentially cost-saving screening approach.
- A combined strategy of modern screening techniques, including HPV testing, and universal HPV vaccination holds the greatest promise for worldwide cervical cancer control.
Related Concept Videos
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
01:24Smallpox
Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
01:51Vaccinations
Overview
01:30Primary Healthcare Services
Primary care promotes wellness and prevents disease. This care includes health promotion, education, protection (such as immunizations), early disease screening, and environmental considerations. Settings providing this type of healthcare include physician offices, public health clinics, school nursing, and community health nursing.
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
01:17Poliomyelitis
Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
01:26Human Virome
The human body harbors a vast and diverse viral community known as the human virome. The virome includes bacteriophages that infect bacteria, and eukaryotic viruses that infect human cells. Transient dietary and environmental viruses also contribute to this dynamic ecosystem. Estimates suggest the human body may contain on the order of 10¹³ viral particles, though abundance varies widely by body site and detection method.Comprehensive characterization of the virome has become possible only with...